Edwards Lifesciences (EW) valuation history
Within its usual range
As of
EW's EV/EBITDA of 29.4x is lower than 67% of its available weekly readings from the last five years.
Share EV/EBITDA history
Chart by stockresearch.app. Reuse with credit under CC BY 4.0.
EV/EBITDA at year-end
Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.
| Reading date | EV/EBITDA | 5-year rank |
|---|---|---|
| 29.5× | 30% | |
| 32.2× | 33% | |
| 33.3× | 32% | |
| 25.1× | 4% | |
| 44.8× | 51% | |
| 59.5× | 100% | |
| 52.8× | 80% | |
| 26.8× | 51% | |
| Unavailable | Short history | |
| Unavailable | Short history |
Loading related research…
About this history
- What is EW's current EV/EBITDA?
- EW's EV/EBITDA of 29.4x is lower than 67% of its available weekly readings from the last five years.
- What is EW's five-year median EV/EBITDA?
- The median, or middle weekly reading, is 30.8× over the last five years. Available history contains 533 weekly observations from Aug 8, 2016 to Oct 19, 2026.
- Does a low historical rank mean a stock is a buy?
- No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.